FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382402529> ?p ?o ?g. }

• W4382402529 endingPage "3373" @default.
• W4382402529 startingPage "3373" @default.
• W4382402529 abstract "Acinic cell carcinoma (AciCC) comprises 6-7% of all salivary gland neoplasms and is the second most common salivary gland malignancy in children. Like many salivary gland carcinomas, it is considered low grade but occasionally it behaves aggressively. Understanding the risk factors associated with recurrence, metastasis, and death is important to determine the counseling and management of individual patients. Older population-based studies are presumed to have been confounded by the misclassification of other neoplasms as AciCC, in particular secretory carcinoma and cystadenocarcinoma. Since diagnostic tools to reliably separate these entities have been available for over a decade, reevaluation of epidemiologic data limited to the 21st century should allow a better characterization of the clinicopathological characteristics of AciCC.Our study extracted data from the Surveillance, Epidemiology, and End Results (SEER) database for the period 2000 to 2018. Cox regression model analysis was performed to identify risk factors independently affecting survival.Data for 2226 patients with AciCC were extracted from the database. Most patients were females: 59%, and white: 80.5%, with a mean age at diagnosis of 51.2 (SD ± 18.7) years. Most cases (81%) were localized at presentation. Tumor size was less than 2 cm in 42%, 2-4 cm in 47%, and >4 cm in 11%. Low-grade tumors had 5-year survival > 90%, whereas high-grade tumors had survival < 50%. Of the patients with known lymph node status only 7.3% had nodal metastases. Distant metastases were documented in 1.1%, involving lungs 44%, bone 40%, liver 12%, and brain 4%. The most common treatment modality was surgery alone: 63.6% followed by surgery and adjuvant radiation: 33%. A few received chemotherapy (1.8%) or multimodality therapy (1.2%). The 5-year overall survival rate was 90.6% (95%CI 89.1-91.9), and disease-specific survival was 94.6% (95%CI 93.3-95.6). Multivariable cox regression analysis showed that undifferentiated (HR = 8.3) and poorly differentiated tumor grade (HR = 6.4), and metastasis (HR = 5.3) were the worst independent prognostic factors. Other poor risk factors included age > 50 (HR = 3.5) and tumor size > 4 cm (HR = 2.5).In the US, AciCC is more common in middle age white females, and most tumors are less than 4 cm and localized at diagnosis. The most relevant negative prognostic factor was high tumor grade which was associated with higher hazard ratios for death than all other variables, including regional or distant metastases at presentation." @default.
• W4382402529 created "2023-06-29" @default.
• W4382402529 creator A5000774255 @default.
• W4382402529 creator A5006075716 @default.
• W4382402529 creator A5007823777 @default.
• W4382402529 creator A5025885634 @default.
• W4382402529 creator A5054436877 @default.
• W4382402529 creator A5056520956 @default.
• W4382402529 creator A5085114579 @default.
• W4382402529 date "2023-06-27" @default.
• W4382402529 modified "2023-10-14" @default.
• W4382402529 title "Acinic Cell Carcinoma in the 21st Century: A Population-Based Study from the SEER Database and Review of Recent Molecular Genetic Advances" @default.
• W4382402529 cites W1075732441 @default.
• W4382402529 cites W1545498922 @default.
• W4382402529 cites W1978902427 @default.
• W4382402529 cites W2036820262 @default.
• W4382402529 cites W2048648869 @default.
• W4382402529 cites W2061006759 @default.
• W4382402529 cites W2090967766 @default.
• W4382402529 cites W2118510514 @default.
• W4382402529 cites W2122566852 @default.
• W4382402529 cites W2274811373 @default.
• W4382402529 cites W2320731469 @default.
• W4382402529 cites W2502134830 @default.
• W4382402529 cites W2518319998 @default.
• W4382402529 cites W2588106078 @default.
• W4382402529 cites W2792466899 @default.
• W4382402529 cites W2803927649 @default.
• W4382402529 cites W2908888879 @default.
• W4382402529 cites W2944888925 @default.
• W4382402529 cites W2947353745 @default.
• W4382402529 cites W3021214815 @default.
• W4382402529 cites W3025216404 @default.
• W4382402529 cites W3093242228 @default.
• W4382402529 cites W3093506315 @default.
• W4382402529 cites W3175069960 @default.
• W4382402529 cites W4206443958 @default.
• W4382402529 cites W4212843845 @default.
• W4382402529 cites W3041794564 @default.
• W4382402529 doi "https://doi.org/10.3390/cancers15133373" @default.
• W4382402529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37444484" @default.
• W4382402529 hasPublicationYear "2023" @default.
• W4382402529 type Work @default.
• W4382402529 citedByCount "0" @default.
• W4382402529 crossrefType "journal-article" @default.
• W4382402529 hasAuthorship W4382402529A5000774255 @default.
• W4382402529 hasAuthorship W4382402529A5006075716 @default.
• W4382402529 hasAuthorship W4382402529A5007823777 @default.
• W4382402529 hasAuthorship W4382402529A5025885634 @default.
• W4382402529 hasAuthorship W4382402529A5054436877 @default.
• W4382402529 hasAuthorship W4382402529A5056520956 @default.
• W4382402529 hasAuthorship W4382402529A5085114579 @default.
• W4382402529 hasBestOaLocation W43824025291 @default.
• W4382402529 hasConcept C107130276 @default.
• W4382402529 hasConcept C121608353 @default.
• W4382402529 hasConcept C126322002 @default.
• W4382402529 hasConcept C142724271 @default.
• W4382402529 hasConcept C143998085 @default.
• W4382402529 hasConcept C2777546739 @default.
• W4382402529 hasConcept C2778039489 @default.
• W4382402529 hasConcept C2778527826 @default.
• W4382402529 hasConcept C2778937882 @default.
• W4382402529 hasConcept C2779391198 @default.
• W4382402529 hasConcept C2779399171 @default.
• W4382402529 hasConcept C2780329156 @default.
• W4382402529 hasConcept C2780395140 @default.
• W4382402529 hasConcept C2780849966 @default.
• W4382402529 hasConcept C2780859518 @default.
• W4382402529 hasConcept C2908647359 @default.
• W4382402529 hasConcept C41008148 @default.
• W4382402529 hasConcept C50382708 @default.
• W4382402529 hasConcept C71924100 @default.
• W4382402529 hasConcept C77088390 @default.
• W4382402529 hasConcept C99454951 @default.
• W4382402529 hasConceptScore W4382402529C107130276 @default.
• W4382402529 hasConceptScore W4382402529C121608353 @default.
• W4382402529 hasConceptScore W4382402529C126322002 @default.
• W4382402529 hasConceptScore W4382402529C142724271 @default.
• W4382402529 hasConceptScore W4382402529C143998085 @default.
• W4382402529 hasConceptScore W4382402529C2777546739 @default.
• W4382402529 hasConceptScore W4382402529C2778039489 @default.
• W4382402529 hasConceptScore W4382402529C2778527826 @default.
• W4382402529 hasConceptScore W4382402529C2778937882 @default.
• W4382402529 hasConceptScore W4382402529C2779391198 @default.
• W4382402529 hasConceptScore W4382402529C2779399171 @default.
• W4382402529 hasConceptScore W4382402529C2780329156 @default.
• W4382402529 hasConceptScore W4382402529C2780395140 @default.
• W4382402529 hasConceptScore W4382402529C2780849966 @default.
• W4382402529 hasConceptScore W4382402529C2780859518 @default.
• W4382402529 hasConceptScore W4382402529C2908647359 @default.
• W4382402529 hasConceptScore W4382402529C41008148 @default.
• W4382402529 hasConceptScore W4382402529C50382708 @default.
• W4382402529 hasConceptScore W4382402529C71924100 @default.
• W4382402529 hasConceptScore W4382402529C77088390 @default.
• W4382402529 hasConceptScore W4382402529C99454951 @default.
• W4382402529 hasIssue "13" @default.
• W4382402529 hasLocation W43824025291 @default.
• W4382402529 hasLocation W43824025292 @default.

• next